Sanxin Medical has issued a convertible bond offering announcement, planning to raise up to 530 million yuan, primarily directed toward core segments such as hemodialysis membranes, dialyzers, dialysis tubing, and sterilization support. Among these, 210 million yuan will be allocated to the renovation and expansion project for an annual output of 10 million bundles of hemodialysis membranes and 10 million hemodialyzers, 166 million yuan to the new construction project for an annual output of 30 million sets of hemodialysis tubing and supporting facilities, and 24 million yuan to the renovation and expansion project for the electron accelerator irradiation sterilization production line at Jiangxi Chengtukang. The remaining funds will be used to supplement working capital. The company's products have been selected in multiple provincial alliance centralized procurements, and its domestically first-certified wet-film dialyzer has also entered the supplementary selection catalog. This fundraising project will help the company meet the volume demand from centralized procurement and accelerate overseas business expansion.
Jiangxi Sanxin Medtec Co LtdCompany launches convertible bond issuance to raise funds for capacity expansion, supporting growth.